{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:01:22Z","timestamp":1762459282146},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.peptides.2015.03.009","type":"journal-article","created":{"date-parts":[[2015,4,5]],"date-time":"2015-04-05T17:06:32Z","timestamp":1428253592000},"page":"154-163","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Endocrine approaches to treatment of Alzheimer's disease and other neurological conditions"],"prefix":"10.1016","volume":"72","author":[{"given":"Andrew V.","family":"Schally","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"October (7887)","key":"10.1016\/j.peptides.2015.03.009_bib0475","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0140-6736(74)92071-6","article-title":"Glucagon control of fasting glucose in man","volume":"2","author":"Alford","year":"1974","journal-title":"Lancet"},{"issue":"December (23)","key":"10.1016\/j.peptides.2015.03.009_bib0480","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJM197112022852302","article-title":"Synthetic thyrotropin-releasing hormone. A potent stimulator of thyrotropin secretion in man","volume":"285","author":"Anderson","year":"1971","journal-title":"N Engl J Med"},{"issue":"February (2)","key":"10.1016\/j.peptides.2015.03.009_bib0485","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/jnen\/64.2.93","article-title":"Dysregulation of the hypothalamic-pituitary-gonadal axis with menopause and andropause promotes neurodegenerative senescence","volume":"64","author":"Atwood","year":"2005","journal-title":"J Neuropathol Exp Neurol"},{"issue":"November (11)","key":"10.1016\/j.peptides.2015.03.009_bib0490","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1001\/archneurol.2012.1970","article-title":"Effects of growth hormone-releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial","volume":"69","author":"Baker","year":"2012","journal-title":"Arch Neurol"},{"issue":"December (51)","key":"10.1016\/j.peptides.2015.03.009_bib0495","doi-asserted-by":"crossref","first-page":"22272","DOI":"10.1073\/pnas.1016369107","article-title":"Effects of a growth hormone-releasing hormone antagonist on telomerase activity, oxidative stress, longevity, and aging in mice","volume":"107","author":"Banks","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"September (17)","key":"10.1016\/j.peptides.2015.03.009_bib0500","doi-asserted-by":"crossref","first-page":"6762","DOI":"10.1073\/pnas.87.17.6762","article-title":"Permeability of the murine blood\u2013brain barrier to some octapeptide analogs of somatostatin","volume":"87","author":"Banks","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"December (51)","key":"10.1016\/j.peptides.2015.03.009_bib0505","doi-asserted-by":"crossref","first-page":"20470","DOI":"10.1073\/pnas.0811209106","article-title":"Antioxidant activity of growth hormone-releasing hormone antagonists in LNCaP human prostate cancer line","volume":"105","author":"Barabutis","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"April (2)","key":"10.1016\/j.peptides.2015.03.009_bib0510","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1385\/ENDO:29:2:257","article-title":"The role of gonadotropins in Alzheimer's disease: potential neurodegenerative mechanisms","volume":"29","author":"Barron","year":"2006","journal-title":"Endocrine"},{"issue":"March (5904)","key":"10.1016\/j.peptides.2015.03.009_bib0515","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1136\/bmj.1.5904.352","article-title":"Growth hormone release inhibiting hormone in acromegaly","volume":"1","author":"Besser","year":"1974","journal-title":"Br Med J"},{"issue":"November (7889)","key":"10.1016\/j.peptides.2015.03.009_bib0520","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S0140-6736(74)90869-1","article-title":"Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone","volume":"2","author":"Bloom","year":"1974","journal-title":"Lancet"},{"issue":"January (1)","key":"10.1016\/j.peptides.2015.03.009_bib0525","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.neurobiolaging.2007.05.017","article-title":"Menopausal transition: a possible risk factor for brain pathologic events","volume":"30","author":"Bonomo","year":"2009","journal-title":"Neurobiol Aging"},{"issue":"April (4)","key":"10.1016\/j.peptides.2015.03.009_bib0530","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1046\/j.1365-2826.2000.00461.x","article-title":"An association of elevated serum gonadotropin concentrations and Alzheimer disease?","volume":"12","author":"Bowen","year":"2000","journal-title":"J Neuroendocrinol"},{"issue":"July (7)","key":"10.1016\/j.peptides.2015.03.009_bib0535","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1210\/jcem-28-7-978","article-title":"Effect of thyrotropin-releasing factor in man","volume":"28","author":"Bowers","year":"1968","journal-title":"J Clin Endocrinol Metab"},{"issue":"May (3)","key":"10.1016\/j.peptides.2015.03.009_bib0540","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/0006-291X(70)90583-8","article-title":"Activity and specificity of synthetic thyrotropin-releasing hormone in man","volume":"39","author":"Bowers","year":"1970","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"10.1016\/j.peptides.2015.03.009_bib0545","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"issue":"February","key":"10.1016\/j.peptides.2015.03.009_bib0550","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.peptides.2013.12.010","article-title":"Synthesis of new potent agonistic analogs of growth hormone-releasing hormone (GHRH) and evaluation of their endocrine and cardiac activities","volume":"52","author":"Cai","year":"2014","journal-title":"Peptides"},{"issue":"December (26)","key":"10.1016\/j.peptides.2015.03.009_bib0555","doi-asserted-by":"crossref","first-page":"12664","DOI":"10.1073\/pnas.91.26.12664","article-title":"Potent bombesin antagonists with C-terminal Leu-psi(CH2-N)-Tac-NH2 or its derivatives","volume":"91","author":"Cai","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"July (5975)","key":"10.1016\/j.peptides.2015.03.009_bib0560","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/bmj.3.5975.67","article-title":"Growth hormone release inhibiting hormone: actions on thyrotrophin and prolactin secretion after thyrotrophin releasing hormone","volume":"3","author":"Carr","year":"1975","journal-title":"Br Med J"},{"issue":"December (12)","key":"10.1016\/j.peptides.2015.03.009_bib0565","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1210\/jc.2012-2063","article-title":"Insulin-like growth factor-I and insulin-like growth factor binding protein-3 in Alzheimer's disease","volume":"97","author":"Duron","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.peptides.2015.03.009_bib0570","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0196-9781(81)90065-6","article-title":"Behavioral and hormonal effects of prolonged high doses of LHRH in male impotency","volume":"2","author":"Ehrensing","year":"1981","journal-title":"Peptides"},{"issue":"February (2)","key":"10.1016\/j.peptides.2015.03.009_bib0575","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/ncpendmet0399","article-title":"Drug insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone","volume":"3","author":"Engel","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"December (6)","key":"10.1016\/j.peptides.2015.03.009_bib0580","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1177\/1073858410366162","article-title":"An amyloid-notch hypothesis for Alzheimer's disease","volume":"16","author":"Ethell","year":"2010","journal-title":"Neuroscientist"},{"issue":"December (48)","key":"10.1016\/j.peptides.2015.03.009_bib0585","doi-asserted-by":"crossref","first-page":"17260","DOI":"10.1073\/pnas.1420375111","article-title":"Agonists of growth hormone-releasing hormone stimulate self-renewal of cardiac stem cells and promote their survival","volume":"111","author":"Florea","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"August (4)","key":"10.1016\/j.peptides.2015.03.009_bib0590","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1037\/0735-7044.107.4.618","article-title":"Severity of spatial learning impairment in aging: development of a learning index for performance in the Morris water maze","volume":"107","author":"Gallagher","year":"1993","journal-title":"Behav Neurosci"},{"issue":"May (9)","key":"10.1016\/j.peptides.2015.03.009_bib0595","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1212\/01.WNL.0000063311.58879.01","article-title":"Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease","volume":"60","author":"Giannakopoulos","year":"2003","journal-title":"Neurology"},{"issue":"November (8046)","key":"10.1016\/j.peptides.2015.03.009_bib0600","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0140-6736(77)92893-8","article-title":"Suppression of gonadotrophin release in many by an inhibitory analogue of L.H.-releasing hormone","volume":"2","author":"Gonzalez-Barcena","year":"1977","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.peptides.2015.03.009_bib0605","first-page":"505","article-title":"Response to acute administration of pituitary inhibiting hormone, growth hormone and one of its analogues in acromegaly","volume":"6","author":"Gonzalez-Barcena","year":"1975","journal-title":"Arch Invest Med (Mex)"},{"issue":"1","key":"10.1016\/j.peptides.2015.03.009_bib0610","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/07435808409046764","article-title":"Effect of Ala-2-D-Trp-8-D-Cys-14-somatostatin on the arginine induced release of insulin, GH and glucagon in normal men","volume":"10","author":"Gonzalez-Barcena","year":"1984","journal-title":"Endocr Res"},{"issue":"24","key":"10.1016\/j.peptides.2015.03.009_bib0615","first-page":"24","article-title":"Alzheimer's \u2013 looking beyond plaques","volume":"3","author":"Griffin","year":"2011","journal-title":"F1000 Med Rep"},{"key":"10.1016\/j.peptides.2015.03.009_bib0620","first-page":"173","article-title":"Clinical experience with hypothalamic releasing hormones. 1. Thyrotropin-releasing hormone","volume":"28","author":"Gual","year":"1972","journal-title":"Recent Prog Horm Res"},{"issue":"July (5580)","key":"10.1016\/j.peptides.2015.03.009_bib0625","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"issue":"August (35)","key":"10.1016\/j.peptides.2015.03.009_bib0630","doi-asserted-by":"crossref","first-page":"12495","DOI":"10.1073\/pnas.0504163102","article-title":"Antagonists of growth hormone-releasing hormone cross the blood\u2013brain barrier: a potential applicability to treatment of brain tumors","volume":"102","author":"Jaeger","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"November (11)","key":"10.1016\/j.peptides.2015.03.009_bib0635","doi-asserted-by":"crossref","first-page":"755","DOI":"10.18632\/aging.100504","article-title":"Beneficial effects of novel antagonists of GHRH in different models of Alzheimer's disease","volume":"4","author":"Jaszberenyi","year":"2012","journal-title":"Aging (Albany NY)"},{"issue":"January (2)","key":"10.1016\/j.peptides.2015.03.009_bib0640","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1073\/pnas.1119203109","article-title":"Activation of growth hormone releasing hormone (GHRH) receptor stimulates cardiac reverse remodeling after myocardial infarction (MI)","volume":"109","author":"Kanashiro-Takeuchi","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"February (6)","key":"10.1016\/j.peptides.2015.03.009_bib0645","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1073\/pnas.0914138107","article-title":"Cardioprotective effects of growth hormone-releasing hormone agonist after myocardial infarction","volume":"107","author":"Kanashiro-Takeuchi","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.peptides.2015.03.009_bib0650","series-title":"Behavioral effects of the brain opiates enkephalin and endorphin","first-page":"273","author":"Kastin","year":"1979"},{"key":"10.1016\/j.peptides.2015.03.009_bib0655","series-title":"Hormone and prostaglandin influences on pigment cells","first-page":"228","article-title":"Effects of MSH on the brain","author":"Kastin","year":"1976"},{"key":"10.1016\/j.peptides.2015.03.009_bib0660","series-title":"Proceedings of the 1st international symposium on psych-neuro-endocrinology","article-title":"Central nervous system effects of MSH and hypothalamic peptides","author":"Kastin","year":"1978"},{"key":"10.1016\/j.peptides.2015.03.009_bib0665","series-title":"The anterior pituitary gland","first-page":"55","article-title":"Early questions involving hypothalamic peptides","author":"Kastin","year":"1983"},{"year":"1980","series-title":"Hypothalamic peptides affect behavior after systemic injection. July 11\u201313, 1979; Baltimore, Maryland","author":"Kastin","key":"10.1016\/j.peptides.2015.03.009_bib0670"},{"key":"10.1016\/j.peptides.2015.03.009_bib0675","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00002826-197800030-00009","article-title":"Clinical effects of hypothalamic-pituitary peptides on the central nervous system","volume":"3","author":"Kastin","year":"1978","journal-title":"Clin Neuropharmacol"},{"issue":"April (4)","key":"10.1016\/j.peptides.2015.03.009_bib0680","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0031-6989(78)80025-3","article-title":"Peripheral administration of hypothalamic peptides results in CNS changes","volume":"10","author":"Kastin","year":"1978","journal-title":"Pharmacol Res Commun"},{"key":"10.1016\/j.peptides.2015.03.009_bib0685","first-page":"201","article-title":"Clinical experience with hypothalamic releasing hormones. 2. Luteinizing hormone-releasing hormone and other hypophysiotropic releasing hormones","volume":"28","author":"Kastin","year":"1972","journal-title":"Recent Prog Horm Res"},{"key":"10.1016\/j.peptides.2015.03.009_bib0690","first-page":"139","article-title":"CNS and pituitary effects of hypothalamic peptides and MSH","volume":"1","author":"Kastin","year":"1977","journal-title":"Essays Neurochem Neuropharmacol"},{"issue":"July (5)","key":"10.1016\/j.peptides.2015.03.009_bib0695","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0024-3205(79)90572-1","article-title":"CNS effects of peripherally administered brain peptides","volume":"25","author":"Kastin","year":"1979","journal-title":"Life Sci"},{"issue":"October (30)","key":"10.1016\/j.peptides.2015.03.009_bib0700","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.2174\/138161210793563491","article-title":"Concepts for biologically active peptides","volume":"16","author":"Kastin","year":"2010","journal-title":"Curr Pharm Des"},{"issue":"April (4)","key":"10.1016\/j.peptides.2015.03.009_bib0705","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1210\/jcem-34-4-753","article-title":"Release of LH and FSH after administration of synthetic LH-releasing hormone","volume":"34","author":"Kastin","year":"1972","journal-title":"J Clin Endocrinol Metab"},{"issue":"February (2)","key":"10.1016\/j.peptides.2015.03.009_bib0710","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1210\/jcem-32-2-287","article-title":"Administration of LH-releasing hormone of human origin to man","volume":"32","author":"Kastin","year":"1971","journal-title":"J Clin Endocrinol Metab"},{"issue":"August (8)","key":"10.1016\/j.peptides.2015.03.009_bib0715","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1210\/jcem-29-8-1046","article-title":"Stimulation of LH release in men and women by LH-releasing hormone purified from porcine hypothalami","volume":"29","author":"Kastin","year":"1969","journal-title":"J Clin Endocrinol Metab"},{"issue":"September (2)","key":"10.1016\/j.peptides.2015.03.009_bib0720","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0002-9378(70)90293-0","article-title":"Administration of LH-releasing hormone to selected subjects","volume":"108","author":"Kastin","year":"1970","journal-title":"Am J Obstet Gynecol"},{"issue":"July (7)","key":"10.1016\/j.peptides.2015.03.009_bib0725","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1172\/JCI106641","article-title":"Dose-response relationship of luteinizing hormone to luteinizing hormone\u2014releasing hormone in man","volume":"50","author":"Kastin","year":"1971","journal-title":"J Clin Invest"},{"issue":"February (2)","key":"10.1016\/j.peptides.2015.03.009_bib0730","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1530\/jrf.0.0280185","article-title":"Anovulatory uterine bleeding after administration of MSH to women with secondary amenorrhoea","volume":"28","author":"Kastin","year":"1972","journal-title":"J Reprod Fertil"},{"issue":"November (4)","key":"10.1016\/j.peptides.2015.03.009_bib0735","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1083\/jcb.200605187","article-title":"Tau-dependent microtubule disassembly initiated by prefibrillar beta-amyloid","volume":"175","author":"King","year":"2006","journal-title":"J Cell Biol"},{"issue":"October (16)","key":"10.1016\/j.peptides.2015.03.009_bib0740","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1001\/jama.2009.1547","article-title":"DNA beta-amyloid(1\u201342) trimer immunization for Alzheimer disease in a wild-type mouse model","volume":"302","author":"Lambracht-Washington","year":"2009","journal-title":"J Am Med Assoc"},{"issue":"March (11)","key":"10.1016\/j.peptides.2015.03.009_bib0745","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1523\/JNEUROSCI.6047-09.2010","article-title":"Localized suppression of cortical growth hormone-releasing hormone receptors state-specifically attenuates electroencephalographic delta waves","volume":"30","author":"Liao","year":"2010","journal-title":"J Neurosci"},{"issue":"June (9)","key":"10.1016\/j.peptides.2015.03.009_bib0750","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1097\/01.wnr.0000221832.33717.48","article-title":"A role for hippocampal gastrin-releasing peptide receptors in extinction of aversive memory","volume":"17","author":"Luft","year":"2006","journal-title":"Neuroreport"},{"key":"10.1016\/j.peptides.2015.03.009_bib0755","article-title":"Profound actions of an agonist of growth hormone releasing hormone on angiogenic therapy by mesenchymal stem cells","author":"Ma","year":"2015","journal-title":"Stem Cells"},{"issue":"December (6012)","key":"10.1016\/j.peptides.2015.03.009_bib0760","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1126\/science.1197623","article-title":"Decreased clearance of CNS beta-amyloid in Alzheimer's disease","volume":"330","author":"Mawuenyega","year":"2010","journal-title":"Science"},{"issue":"May (1)","key":"10.1016\/j.peptides.2015.03.009_bib0765","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0165-0270(84)90007-4","article-title":"Developments of a water-maze procedure for studying spatial learning in the rat","volume":"11","author":"Morris","year":"1984","journal-title":"J Neurosci Methods"},{"issue":"April (7860)","key":"10.1016\/j.peptides.2015.03.009_bib0770","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0140-6736(74)92903-1","article-title":"Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients","volume":"1","author":"Mortimer","year":"1974","journal-title":"Lancet"},{"issue":"September (9)","key":"10.1016\/j.peptides.2015.03.009_bib0775","doi-asserted-by":"crossref","first-page":"988","DOI":"10.18632\/oncotarget.634","article-title":"Antagonists of growth hormone-releasing hormone suppress in vivo tumor growth and gene expression in triple negative breast cancers","volume":"3","author":"Perez","year":"2012","journal-title":"Oncotarget"},{"issue":"October (8)","key":"10.1016\/j.peptides.2015.03.009_bib0780","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/0024-3205(76)90265-4","article-title":"Neuropharmacological actions of enkephalin after systemic administration","volume":"19","author":"Plotnikoff","year":"1976","journal-title":"Life Sci"},{"issue":"December (11)","key":"10.1016\/j.peptides.2015.03.009_bib0785","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/0024-3205(75)90114-9","article-title":"Gonadotropin releasing hormone (GnRH): neuropharmacological studies","volume":"17","author":"Plotnikoff","year":"1975","journal-title":"Life Sci"},{"issue":"January (4)","key":"10.1016\/j.peptides.2015.03.009_bib0790","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer's disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N Engl J Med"},{"issue":"December (6)","key":"10.1016\/j.peptides.2015.03.009_bib0795","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1399-3011.1991.tb01545.x","article-title":"Biological effects and receptor binding affinities of new pseudononapeptide bombesin\/GRP receptor antagonists with N-terminal D-Trp or D-Tpi","volume":"38","author":"Radulovic","year":"1991","journal-title":"Int J Pept Protein Res"},{"issue":"October (4)","key":"10.1016\/j.peptides.2015.03.009_bib0800","first-page":"749","article-title":"New antagonists of bombesin gastrin-releasing Peptide with C-terminal leu-psi-(ch2n)tac-nh2","volume":"7","author":"Reile","year":"1995","journal-title":"Int J Oncol"},{"issue":"1","key":"10.1016\/j.peptides.2015.03.009_bib0805","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/02699052.2010.536196","article-title":"Effects of growth hormone (GH) replacement and cognitive rehabilitation in patients with cognitive disorders after traumatic brain injury","volume":"25","author":"Reimunde","year":"2011","journal-title":"Brain Inj"},{"issue":"March (3)","key":"10.1016\/j.peptides.2015.03.009_bib0810","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrneurol.2011.2","article-title":"Epidemiology of Alzheimer disease","volume":"7","author":"Reitz","year":"2011","journal-title":"Nat Rev Neurol"},{"issue":"March (9)","key":"10.1016\/j.peptides.2015.03.009_bib0815","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1073\/pnas.1018086108","article-title":"Antagonists of growth hormone-releasing hormone (GHRH) reduce prostate size in experimental benign prostatic hyperplasia","volume":"108","author":"Rick","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"May (5825)","key":"10.1016\/j.peptides.2015.03.009_bib0820","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1126\/science.1141736","article-title":"Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model","volume":"316","author":"Roberson","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.peptides.2015.03.009_bib0825","unstructured":"Salgueiro LM, Schally AV. [in press]."},{"issue":"11","key":"10.1016\/j.peptides.2015.03.009_bib0830","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0015-0282(16)38580-6","article-title":"Hypothalamic follicle-stimulating hormone (FSH) and luteinizing hormone (LH)-regulating hormone: structure, physiology, and clinical studies","volume":"22","author":"Schally","year":"1971","journal-title":"Fertil Steril"},{"issue":"January (1)","key":"10.1016\/j.peptides.2015.03.009_bib0835","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/ncpendmet0677","article-title":"Antagonists of growth-hormone-releasing hormone: an emerging new therapy for cancer","volume":"4","author":"Schally","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"December (4)","key":"10.1016\/j.peptides.2015.03.009_bib0840","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1177\/0891988710383574","article-title":"Genetic causes of frontotemporal degeneration","volume":"23","author":"See","year":"2010","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"April (2)","key":"10.1016\/j.peptides.2015.03.009_bib0845","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","article-title":"Alzheimer's disease: genes, proteins, and therapy","volume":"81","author":"Selkoe","year":"2001","journal-title":"Physiol Rev"},{"key":"10.1016\/j.peptides.2015.03.009_bib0850","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/B978-0-12-386986-9.00003-X","article-title":"The blood\u2013brain barrier in Alzheimer's disease: novel therapeutic targets and nanodrug delivery","volume":"102","author":"Sharma","year":"2012","journal-title":"Int Rev Neurobiol"},{"issue":"April (4)","key":"10.1016\/j.peptides.2015.03.009_bib0855","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1001\/archneur.59.4.611","article-title":"Differences in tau and apolipoprotein E polymorphism frequencies in sporadic frontotemporal lobar degeneration syndromes","volume":"59","author":"Short","year":"2002","journal-title":"Arch Neurol"},{"issue":"July (27)","key":"10.1016\/j.peptides.2015.03.009_bib0860","doi-asserted-by":"crossref","first-page":"11025","DOI":"10.1073\/pnas.1206555109","article-title":"Purified and synthetic Alzheimer's amyloid beta (Abeta) prions","volume":"109","author":"Stohr","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"March (6075)","key":"10.1016\/j.peptides.2015.03.009_bib0865","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1126\/science.1220725","article-title":"Medicine Old drug, new hope for Alzheimer's disease","volume":"335","author":"Strittmatter","year":"2012","journal-title":"Science"},{"issue":"August (2)","key":"10.1016\/j.peptides.2015.03.009_bib0870","doi-asserted-by":"crossref","first-page":"R922","DOI":"10.1152\/ajpregu.00237.2007","article-title":"Growth hormone-releasing hormone: cerebral cortical sleep-related EEG actions and expression","volume":"293","author":"Szentirmai","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"January (1\u20133)","key":"10.1016\/j.peptides.2015.03.009_bib0875","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.regpep.2009.08.005","article-title":"Effects of the LHRH antagonist Cetrorelix on affective and cognitive functions in rats","volume":"159","author":"Telegdy","year":"2010","journal-title":"Regul Pept"},{"issue":"July (1)","key":"10.1016\/j.peptides.2015.03.009_bib0880","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.bbr.2012.04.011","article-title":"Neurotransmitter-mediated action of an antagonist of growth hormone-releasing hormone on anxiolysis in mice","volume":"233","author":"Telegdy","year":"2012","journal-title":"Behav Brain Res"},{"issue":"October (1)","key":"10.1016\/j.peptides.2015.03.009_bib0885","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.bbr.2011.05.036","article-title":"Effects of the growth hormone-releasing hormone (GH-RH) antagonist on brain functions in mice","volume":"224","author":"Telegdy","year":"2011","journal-title":"Behav Brain Res"},{"issue":"June (3)","key":"10.1016\/j.peptides.2015.03.009_bib0890","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.npep.2009.03.001","article-title":"Effects of the LHRH antagonist Cetrorelix on the brain function in mice","volume":"43","author":"Telegdy","year":"2009","journal-title":"Neuropeptides"},{"issue":"May (3)","key":"10.1016\/j.peptides.2015.03.009_bib0895","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0143-4179(84)90106-9","article-title":"Effects of H-Phe-Ile-Tyr-His-Ser-Tyr-Lys-OH on the in vitro uptake and release of radiolabelled dopamine, noradrenaline and serotonin in rat brain hypothalamic slices","volume":"4","author":"Telegdy","year":"1984","journal-title":"Neuropeptides"},{"issue":"June (3)","key":"10.1016\/j.peptides.2015.03.009_bib0900","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0143-4179(85)90089-7","article-title":"The role of central dopaminergic systems in the behavioral effects of H-Phe-Ile-Tyr-His-Ser-Tyr-Lys-OH","volume":"6","author":"Vecsei","year":"1985","journal-title":"Neuropeptides"},{"issue":"February (2)","key":"10.1016\/j.peptides.2015.03.009_bib0905","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.neurobiolaging.2005.01.010","article-title":"Growth hormone releasing hormone improves the cognition of healthy older adults","volume":"27","author":"Vitiello","year":"2006","journal-title":"Neurobiol Aging"},{"issue":"2","key":"10.1016\/j.peptides.2015.03.009_bib0910","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nprot.2006.116","article-title":"Morris water maze: procedures for assessing spatial and related forms of learning and memory","volume":"1","author":"Vorhees","year":"2006","journal-title":"Nat Protoc"},{"issue":"October (6001)","key":"10.1016\/j.peptides.2015.03.009_bib0915","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1126\/science.1194653","article-title":"Tau reduction prevents Abeta-induced defects in axonal transport","volume":"330","author":"Vossel","year":"2010","journal-title":"Science"},{"issue":"April (4)","key":"10.1016\/j.peptides.2015.03.009_bib0920","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1365-2265.1979.tb02098.x","article-title":"Comparison of long-acting analogues of luteinizing hormone releasing hormone in man","volume":"10","author":"Wass","year":"1979","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"February","key":"10.1016\/j.peptides.2015.03.009_bib0925","first-page":"11","article-title":"High prevalence of chronic pituitary and target-organ hormone abnormalities after blast-related mild traumatic brain injury","volume":"3","author":"Wilkinson","year":"2012","journal-title":"Front Neurol"},{"issue":"April (6624)","key":"10.1016\/j.peptides.2015.03.009_bib0930","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/386499a0","article-title":"A potent and selective endogenous agonist for the mu-opiate receptor","volume":"386","author":"Zadina","year":"1997","journal-title":"Nature"},{"issue":"September (9)","key":"10.1016\/j.peptides.2015.03.009_bib0935","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0015-0282(16)39196-8","article-title":"Successful induction of ovulation with synthetic luteinizing hormone-releasing hormone in anovulatoy infertility","volume":"23","author":"Zarate","year":"1972","journal-title":"Fertil Steril"},{"key":"10.1016\/j.peptides.2015.03.009_bib0940","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1750-1326-1-5","article-title":"The amyloid precursor protein: beyond amyloid","volume":"July (1)","author":"Zheng","year":"2006","journal-title":"Mol Neurodegener"}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978115000674?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978115000674?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T06:18:07Z","timestamp":1717827487000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978115000674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":94,"alternative-id":["S0196978115000674"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2015.03.009","relation":{},"ISSN":["0196-9781"],"issn-type":[{"type":"print","value":"0196-9781"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endocrine approaches to treatment of Alzheimer's disease and other neurological conditions","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2015.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}